Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Health Technology Assessment (Winchester, England)|March 13, 2025
Management of diarrhoea in patients with stable ulcerative colitis with low FODMAP diet, amitriptyline, ondansetron or loperamide: the MODULATE RCTLauren A Moreau, Alexander Charles Ford, Matthew James Brookes, et al.
Alimentary Pharmacology & Therapeutics|March 3, 2023
Randomised, placebo-controlled trial and meta-analysis show benefit of ondansetron for irritable bowel syndrome with diarrhoea: The TRITON trialDavid Gunn, Rabia Topan, Lorna Barnard, et al.
Implementation Science : IS|May 26, 2022
A randomised fractional factorial screening experiment to predict effective features of audit and feedbackAlexandra Wright-Hughes, Thomas A Willis, Stephanie Wilson, et al.
Trials|June 26, 2016
Evaluating the effectiveness and cost-effectiveness of Dementia Care Mapping™ to enable person-centred care for people with dementia and their carers (DCM-EPIC) in care homes: study protocol for a randomised controlled trialClaire A Surr, Rebecca E A Walwyn, Amanda Lilley-Kelly, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|August 27, 2024
Low-dose amitriptyline for irritable bowel syndrome: a qualitative study of patients' and GPs' views and experiencesEmma J Teasdale, Hazel A Everitt, Sarah L Alderson, et al.
Health Technology Assessment (Winchester, England)|October 14, 2024
Low-dose titrated amitriptyline as second-line treatment for adults with irritable bowel syndrome in primary care: the ATLANTIS RCTAlexandra Wright-Hughes, Alexander C Ford, Sarah L Alderson, et al.
Translational Behavioral Medicine|December 10, 2024
Assessing multidimensional fidelity in a pilot optimization trial: A process evaluation of four intervention components supporting medication adherence in women with breast cancerSophie M C Green, Christopher D Graham, Michelle Collinson, et al.
Health Technology Assessment (Winchester, England)|March 29, 2020
Dementia Care Mapping™ to reduce agitation in care home residents with dementia: the EPIC cluster RCTClaire A Surr, Ivana Holloway, Rebecca Ea Walwyn, et al.
Lancet (London, England)|October 20, 2023
Amitriptyline at Low-Dose and Titrated for Irritable Bowel Syndrome as Second-Line Treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trialAlexander C Ford, Alexandra Wright-Hughes, Sarah L Alderson, et al.
Aging & Mental Health|April 14, 2020
Effectiveness of Dementia Care Mapping™ to reduce agitation in care home residents with dementia: an open-cohort cluster randomised controlled trialClaire A Surr, Ivana Holloway, Rebecca E A Walwyn, et al.
Pageof 7